If you look at the 20 year chart, it was at the bottom of the chart share price wise in 2005, under $100 or even even $10/share. At the OTC share price of $17,500/share it has 10:1 PE now :-)
One that I loaded the bottom on in 2009, a dead biotech at .001 was brought back in a R/S R/M and is now around $26/share on Nasdaq . That is why I never listen to claims that all OTC stocks are scams.
Is anyone interested in seeing the DD I found on $NDTP 's newest genius addition, Dr. Mark Kester?
Like the over 400 papers and citations of his work, that outnumbers Dr. Michael Fountan's R&D published work and citations by 100:1?
I have not mined Kester's patents yet, been too busy. Maybe over the holidays I will have time
Bid and ask on NDTP is creeping higher :-)
News 
Market Data 
Discover 
